An intravitreal triamcinolone acetonide-moxifloxacin injection during cataract surgery maintained postoperative central macular thickness stability in patients with preexisting diabetic retinopathy, according to a study.
“Intravitreal triamcinolone-moxifloxacin during cataract surgery is an excellent option to consider when operating on patients with diabetic retinopathy, especially with preexisting macular edema. The treatment stabilizes diabetic macular edema during the postoperative period and eliminates compliance concerns regarding postoperative eye drop use. This is my preferred
Uncategorized